dipyridamole has been researched along with Disease, Pulmonary in 9 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Several immunostimulating drugs--levamisole (decaris), Gamma-A, dipyridamole (Antistenocardin), Respivax--were included in the treatment of 161 patients with frequently recurring chronic nonspecific lung diseases and data for suppression of various components of the immune system." | 3.67 | [Evaluation of immunostimulating agents used in pulmonologic practice]. ( Iankov, K; Kis'ova, K; Peneva, M; Tsonev, A; Zlatanov, Z, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (88.89) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weishaar, RE | 1 |
| Cain, MH | 1 |
| Bristol, JA | 1 |
| JAHN, O | 1 |
| Ji, C | 1 |
| Na, W | 1 |
| Fei, X | 1 |
| Sheng-Jun, C | 1 |
| Jia-Bi, Z | 1 |
| Dewanjee, MK | 1 |
| Fuster, V | 1 |
| Rao, SA | 1 |
| Forshaw, PL | 1 |
| Kaye, MP | 1 |
| Nolte, D | 1 |
| Häusl, B | 1 |
| Bolanowski, PJ | 1 |
| Bauer, J | 1 |
| Machiedo, G | 1 |
| Neville, WE | 1 |
| Kis'ova, K | 1 |
| Zlatanov, Z | 1 |
| Peneva, M | 1 |
| Iankov, K | 1 |
| Tsonev, A | 1 |
| Yokoyama, H | 1 |
| Osugi, S | 1 |
1 review available for dipyridamole and Disease, Pulmonary
| Article | Year |
|---|---|
A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Blood Platelets; | 1985 |
1 trial available for dipyridamole and Disease, Pulmonary
| Article | Year |
|---|---|
[Effectiveness of "oxygen-multistep-therapy"].
Topics: Aged; Ascorbic Acid; Dipyridamole; Female; Humans; Isosorbide Dinitrate; Lung Diseases; Male; Middle | 1980 |
7 other studies available for dipyridamole and Disease, Pulmonary
| Article | Year |
|---|---|
[The effects of persantin on residual volume].
Topics: Dipyridamole; Lung Diseases; Lung Volume Measurements; Residual Volume; Spirometry; Vasodilator Agen | 1960 |
Characterization, lung targeting profile and therapeutic efficiency of dipyridamole liposomes.
Topics: Animals; Area Under Curve; Bronchoalveolar Lavage Fluid; Dipyridamole; Drug Delivery Systems; Lipopo | 2006 |
Noninvasive radioisotopic technique for detection of platelet deposition in mitral valve prostheses and quantitation of visceral microembolism in dogs.
Topics: Animals; Aspirin; Blood Platelets; Brain Diseases; Dipyridamole; Dogs; Embolism; Heart Valve Prosthe | 1983 |
Prostaglandin influence on pulmonary intravascular leukocytic aggregation during cardiopulmonary bypass.
Topics: Animals; Cardiopulmonary Bypass; Cell Aggregation; Dipyridamole; Disease Models, Animal; Dogs; Leuko | 1977 |
[Evaluation of immunostimulating agents used in pulmonologic practice].
Topics: Adjuvants, Immunologic; Bacterial Vaccines; Chronic Disease; Dipyridamole; Drug Evaluation; gamma-Gl | 1989 |
[Clinical physiopathological studies on myocardial oxygen metabolism. 3. Myocardial oxygen metabolism during administration of coronary dilators].
Topics: Adolescent; Adult; Aged; Benzoates; Benzofurans; Coronary Disease; Coumarins; Dipyridamole; Female; | 1971 |
[Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
Topics: Adolescent; Adult; Aged; Benzoates; Benzofurans; Blood Flow Velocity; Blood Pressure; Coronary Disea | 1971 |